KKR-owned Healthium, Temasek-backed Romsons in race to buy 70-80% stake in BL Lifesciences

KKR-owned Healthium Medtech and Romsons Group are reportedly competing to acquire a significant stake in BL Lifesciences. The company is expected to be valued between ₹1,800 and ₹2,000 crore during this stake sale. KPMG is providing advisory services to the promoters of BL Lifesciences for this transaction, which involves a family-owned business. BL Lifesciences specializes in various medical devices for surgeries, critical care, and more.